Stockreport

Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company fo [Read more]